A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis
NCT00230529
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
249
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
infliximab
Sponsor
Centocor, Inc.